Accession Number: | 0001209191-22-024785 |
Date: | 2022-04-15 |
Issuer: | MYOVANT SCIENCES LTD. (MYOV) |
Original Submission Date: |
MERENDINO LAUREN
C/O MYOVANT SCIENCES INC.
2000 SIERRA POINT PARKWAY, 9TH FLOOR
BRISBANE, CA 94005
Title of Security | Transaction Date | 2a. Deemed Execution Date | Transaction Code | Shares | Acquired or Disposed | Price per share | 5. Amount of Securities Beneficially Owned Following Reported Transaction | 6. Ownership Form Direct or Indirect | Nature of Indirect Ownership |
---|---|---|---|---|---|---|---|---|---|
COMMON SHARES | 2022-04-15 | A | 103,703 | a | $0.00 | 182,002 | direct |
Title of Derivative Security | Conversion or Exercise Price of Derivative Security | Transaction Date | Deemed Execution Date | Transaction Code | Number of Derivative Securities Acquired (A) or Disposed of (D) | Date Exercisable | Expiration Date | Title and Amount of Securities Underlying Derivative Security | Price of Derivative Security | Number of derivative Securities Beneficially Owned Following Reported Transaction(s) | Ownership Form: Direct (D) or Indirect (I) | Nature of Indirect Beneficial Ownership |
---|
ID | footnote |
---|---|
f1 | the common shares are to be acquired upon the vesting of certain restricted stock units ("rsus") granted to the reporting person. 1/4 of the common shares underlying the rsus vest on april 15, 2023, and 1/16 of the common shares underlying the rsus vest each quarter thereafter, provided the reporting person has provided continuous service to the issuer or its affiliates on each such date. |